Tff Pharmaceuticals Inc Stock
Tff Pharmaceuticals Inc Stock price
Key metrics
| Market capitalization | $1.30m |
| Enterprise Value | $-3.02m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | 0.22 |
| P/B ratio (TTM) P/B ratio | 0.21 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-20.75m |
| Free Cash Flow (TTM) Free Cash Flow | $-13.67m |
| Cash position | $4.39m |
Is Tff Pharmaceuticals Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
Tff Pharmaceuticals Inc Stock Analysis
Analyst Opinions
1 Analyst has issued a forecast Tff Pharmaceuticals Inc:
Analyst Opinions
1 Analyst has issued a forecast Tff Pharmaceuticals Inc:
Financial data from Tff Pharmaceuticals Inc
| Jun '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.54 -0.54 |
15%
15%
|
|
| EBITDA | -20 -20 |
25%
25%
|
EBIT (Operating Income) EBIT | -21 -21 |
24%
24%
|
| Net Profit | -19 -19 |
27%
27%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Tff Pharmaceuticals Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Tff Pharmaceuticals Inc Stock News
Company Profile
TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It intends to initially focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company has a research collaboration with the University of Georgia's Center for Vaccines and Immunology (CVI), along with the University of Texas at Austin (UT Austin), to evaluate the immunogenicity of universal influenza vaccines; and cooperative research and development agreement with United States Army Medical Research Institute of Infectious Diseases for use of its thin film freezing technology platform. TFF Pharmaceuticals, Inc. was founded in 2018 and is based in Austin, Texas.
| Head office | United States |
| CEO | Craig Jalbert |
| Employees | 19 |
| Founded | 2018 |
| Website | www.tffpharma.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
